Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Journal of Pediatric Hematology/Oncology|July 2, 2019
A Potential Role For Apparent Diffusion Coefficient in the Diagnosis of Trilateral RetinoblastomaSameer Farouk Sait, Sofia Haque, Sasan Karimi, et al.Cancer|February 15, 2013
A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancerMatthew G Fury, Eric Sherman, Alan L Ho, et al.Thyroid : Official Journal of the American Thyroid Association|November 29, 2012
Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinomaEric J Sherman, Yungpo Bernard Su, Ashima Lyall, et al.Cancer|March 15, 2012
A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancerMatthew G Fury, Nancy Y Lee, Eric Sherman, et al.Cancer|June 30, 2017
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancerEric J Sherman, Lara A Dunn, Alan L Ho, et al.Investigational New Drugs|February 26, 2014
A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancerAlan L Ho, Brynna L Lipson, Eric J Sherman, et al.Breast Cancer Research : BCR|August 3, 2017
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancerKomal Jhaveri, Rui Wang, Eleonora Teplinsky, et al.Pediatric Blood & Cancer|December 31, 2016
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumorsOren J Becher, Stephen W Gilheeney, Yasmin Khakoo, et al.AJNR. American Journal of Neuroradiology|June 4, 2026
CT-to-FLAIR Style Transfer Improves Perilesional Edema Conspicuity in Brain MetastasesDylan G Hsu, Adhithya Narayanan, Bala McRae-Posani, et al.Cancer Discovery|June 9, 2018
A Secondary Mutation in BRAF Confers Resistance to RAF Inhibition in a BRAFV600E-Mutant Brain TumorJiawan Wang, Zhan Yao, Philip Jonsson, et al.Pageof 5